课题基金 / 基金详情

Molecular characterisation of a new survival pathway in haematopoietic cells

Molecular characterisation of a new survival pathway in haematopoietic cells
造血细胞新生存途径的分子表征
批准号:
nhmrc : 1022916
负责人:
A/Pr Paul Ekert
金额:
$38.12万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2012
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2012-01-01 至 2014-12-31

项目摘要

项目成果

A/Pr Paul Ekert的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It is critical for normal health that cells regulate their responses to changes in the the extracellular environment. Receptors on the cell surface are triggered by specific proteins called cytokines, and relay information to the cell interior. These messages include signaling whether cells should survive and proliferate. Inappropriate activation of signals for survival and proliferation is a hallmark of cancer. We are investigating a new survival signal and how this contributes to the survival of normal cells and to diseases such as leukaemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interleukin-3 receptor signaling is a driver of myeloid leukaemia and a significant therapeutic target
  • 批准号:
    nhmrc : GNT1103244
  • 项目类别:
    Project Grants
  • 资助金额:
    $60.2万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Paul Ekert
  • 依托单位:
Interleukin-3 receptor signaling is a driver of myeloid leukaemia and a significant therapeutic target
  • 批准号:
    nhmrc : 1103244
  • 项目类别:
    Project Grants
  • 资助金额:
    $41.28万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Paul Ekert
  • 依托单位:
Does CD123 provide a biological advantage to leukaemia stem cells?
  • 批准号:
    nhmrc : 1048071
  • 项目类别:
    Project Grants
  • 资助金额:
    $43.18万
  • 财政年份:
    2013
  • 负责人:
    A/Pr Paul Ekert
  • 依托单位:
Identifying the critical components of growth factor-mediated survival pathways
  • 批准号:
    nhmrc : 565212
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $39.3万
  • 财政年份:
    2009
  • 负责人:
    A/Pr Paul Ekert
  • 依托单位:
海外基金